Clinical Edge Journal Scan

Family history and smoking linked to higher RA risk


 

Key clinical point: Smokers with a family history of rheumatoid arthritis (RA) may be considered a high-risk group who should be informed about increased smoking-associated RA risk and advised smoking cessation.

Major finding: Risk for RA was higher in individuals with vs without first-degree relatives affected with RA (adjusted hazard ratio [aHR] 4.49; 95% CI 3.96-5.10) and in current vs non-smokers (aHR 1.37; 95% CI 1.24-1.51), with the risk being markedly higher among smokers with a positive family history of RA (HR 6.44; 95% CI 4.61-9.00).

Study details: Findings are from a population-based cohort study that evaluated lifestyle factors and family relationships of 5,524,403 individuals with (n = 76,065) and without (n = 5,448,338) first-degree relatives affected with RA, of which 47,942 individuals developed RA.

Disclosures: This study was supported by the Chungbuk National University Korea National University Development Project. The authors declared no conflicts of interest.

Source: Kim HJ et al. Familial risk of seropositive rheumatoid arthritis and interaction with smoking: a population-based cohort study. Rheumatology (Oxford) . 2023 (Jan 24). Doi: 10.1093/rheumatology/kead048

Recommended Reading

UnitedHealthcare tried to deny coverage to a chronically ill patient. He fought back, exposing the insurer’s inner workings.
MDedge Rheumatology
Biosimilars perform identically to originator biologics in natural experiment
MDedge Rheumatology
Health plans get very poor scores for access to autoimmune drugs
MDedge Rheumatology
Sarilumab shows long-term safety and efficacy in RA
MDedge Rheumatology
Concomitant methotrexate-glucocorticoid raises bacterial infection risk in RA patients taking bDMARD
MDedge Rheumatology
Treat-to-target management improves cardiovascular outcomes in early RA
MDedge Rheumatology
Pregnant women with RA and their infants at risk for adverse outcomes and rehospitalization
MDedge Rheumatology
RA raises the risk for end-stage renal disease
MDedge Rheumatology
Reduction in radiographic progression similar with strict and lenient treat-to-target approaches in RA
MDedge Rheumatology
Trends in prevalence, incidence, and medication for ILD in RA
MDedge Rheumatology